首页> 外文期刊>Research Journal of Biological Sciences >Evaluation of Safe Attenuated Vibrio alginolyticus for Oral Vaccination of Lates calcarifer Against Vibriosis
【24h】

Evaluation of Safe Attenuated Vibrio alginolyticus for Oral Vaccination of Lates calcarifer Against Vibriosis

机译:安全减毒的藻溶弧菌用于晚期鳞翅目抗弧菌病口服疫苗的评估

获取原文
           

摘要

Safe attenuation has been done on marine pathogen Vibrio alginolyticus using naturally acidified fructose against vibriosis. Attenuation was confirmed by injecting the attenuated bacterium into fish where the survival rate was 100% compared to 50% survival in fish injected with non-attenuated bacteria. The attenuated bacterium was then evaluated for oral vaccination of Lates calcarifer (Asian seabass). Fish were fed with fish pellet incorporated with attenuated and non-attenuated bacterium of V. alginolyticus for 30 days. They were measured for serum antibody production by conventional agglutination titer and also monitored for the fish weight gain to observe the health improvement. Vaccinated fish showed comparable increased in weight gain, 90% survival after challenge and significantly high antibody titer compared to other treatment and control.
机译:使用天然酸化的果糖抵抗弧菌病,已经对海洋病原体溶藻弧菌进行了安全减毒。通过将减毒细菌注射到鱼类中来确认衰减,该鱼类的存活率为100%,而注射非减毒细菌的鱼类的存活率为50%。然后评估减毒细菌的口蹄疫(亚洲鲈鱼)的口服疫苗接种。向鱼喂食掺有溶藻弧菌减毒和非减毒细菌的鱼丸30天。通过常规凝集滴定度测量它们的血清抗体产生,并监测鱼的体重增加以观察健康状况。与其他处理和对照相比,接种疫苗的鱼在体重增加,攻击后90%的存活率和显着高的抗体滴度方面具有可比的增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号